{"id":"https://openalex.org/W4399298247","doi":"https://doi.org/10.1158/1078-0432.25956223.v1","title":"Supplementary Figure S5 from Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy","display_name":"Supplementary Figure S5 from Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy","publication_year":2024,"publication_date":"2024-06-03","ids":{"openalex":"https://openalex.org/W4399298247","doi":"https://doi.org/10.1158/1078-0432.25956223.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.25956223.v1","doi":"https://doi.org/10.1158/1078-0432.25956223.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.25956223.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.25956223.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070919133","display_name":"Mark Jesus M. Magbanua","orcid":"https://orcid.org/0000-0003-2113-3593","observed_orcids":["https://orcid.org/0000-0003-2113-3593"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Jesus M. Magbanua","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2113-3593","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086849405","display_name":"Ziad Ahmed","orcid":"https://orcid.org/0000-0003-1379-5124","observed_orcids":["https://orcid.org/0000-0003-1379-5124"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ziad Ahmed","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1379-5124","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073776710","display_name":"Rosalyn W. Sayaman","orcid":"https://orcid.org/0000-0003-1343-0619","observed_orcids":["https://orcid.org/0000-0003-1343-0619"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosalyn W. Sayaman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1343-0619","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023245303","display_name":"Lamorna Brown Swigart","orcid":"https://orcid.org/0000-0003-2076-5177","observed_orcids":["https://orcid.org/0000-0003-2076-5177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lamorna Brown Swigart","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2076-5177","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076178845","display_name":"Gillian L. Hirst","orcid":"https://orcid.org/0000-0002-4502-0035","observed_orcids":["https://orcid.org/0000-0002-4502-0035"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gillian L. Hirst","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4502-0035","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062190609","display_name":"Christina S. F. Yau","orcid":"https://orcid.org/0000-0002-1937-0859","observed_orcids":["https://orcid.org/0000-0002-1937-0859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Yau","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1937-0859","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005988887","display_name":"Denise M. Wolf","orcid":"https://orcid.org/0000-0002-3676-653X","observed_orcids":["https://orcid.org/0000-0002-3676-653X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Denise M. Wolf","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3676-653X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100320231","display_name":"Wen Li","orcid":"https://orcid.org/0000-0001-6584-363X","observed_orcids":["https://orcid.org/0000-0001-6584-363X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wen Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6584-363X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056987925","display_name":"Amy L. Delson","orcid":"https://orcid.org/0000-0002-2837-3218","observed_orcids":["https://orcid.org/0000-0002-2837-3218"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy L. Delson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2837-3218","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071749616","display_name":"Jane Perlmutter","orcid":"https://orcid.org/0000-0001-5008-0406","observed_orcids":["https://orcid.org/0000-0001-5008-0406"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jane Perlmutter","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5008-0406","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022876688","display_name":"Paula Raffin Pohlmann","orcid":"https://orcid.org/0000-0001-7914-5162","observed_orcids":["https://orcid.org/0000-0001-7914-5162"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula Pohlmann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7914-5162","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001315712","display_name":"W. Fraser Symmans","orcid":"https://orcid.org/0000-0002-1526-184X","observed_orcids":["https://orcid.org/0000-0002-1526-184X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Fraser Symmans","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1526-184X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033966004","display_name":"Douglas Yee","orcid":"https://orcid.org/0000-0002-3387-4009","observed_orcids":["https://orcid.org/0000-0002-3387-4009"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas Yee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3387-4009","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034796205","display_name":"Nola M. Hylton","orcid":"https://orcid.org/0000-0002-6747-1662","observed_orcids":["https://orcid.org/0000-0002-6747-1662"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nola M. Hylton","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6747-1662","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072789687","display_name":"Laura J. Esserman","orcid":"https://orcid.org/0000-0001-9202-4568","observed_orcids":["https://orcid.org/0000-0001-9202-4568"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura J. Esserman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9202-4568","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005537242","display_name":"Angela M. DeMichele","orcid":"https://orcid.org/0000-0003-1297-4251","observed_orcids":["https://orcid.org/0000-0003-1297-4251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela M. DeMichele","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1297-4251","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090188675","display_name":"Hope S. Rugo","orcid":"https://orcid.org/0000-0001-6710-4814","observed_orcids":["https://orcid.org/0000-0001-6710-4814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hope S. Rugo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6710-4814","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014135109","display_name":"Laura van \u2018t Veer","orcid":"https://orcid.org/0000-0002-9838-8298","observed_orcids":["https://orcid.org/0000-0002-9838-8298"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura J. van 't Veer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9838-8298","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.47749999165534973,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.47749999165534973,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.4740999937057495,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/residual-cancer-burden","display_name":"residual cancer burden","score":0.7670000195503235},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9490000009536743},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9330000281333923},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.8840000033378601},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.8270000219345093},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.503000020980835},{"id":"https://openalex.org/keywords/plasma-biomarkers","display_name":"plasma biomarkers","score":0.5230000019073486},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.8949999809265137}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7337273359298706},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.7224621772766113},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6954877376556396},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6174286007881165},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5980604887008667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5649846792221069},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4625953733921051},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.44834962487220764},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.41002801060676575},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17257389426231384},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09192335605621338}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.25956223.v1","doi":"https://doi.org/10.1158/1078-0432.25956223.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.25956223.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/25956223","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S5_from_Cell-free_DNA_Concentration_as_a_Biomarker_of_Response_and_Recurrence_in_HER2-Negative_Breast_Cancer_Receiving_Neoadjuvant_Chemotherapy/25956223","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.25956223.v1","doi":"https://doi.org/10.1158/1078-0432.25956223.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.25956223.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8600000143051147}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391375266","https://openalex.org/W2533581028","https://openalex.org/W2090817358","https://openalex.org/W2111160383","https://openalex.org/W2056890439","https://openalex.org/W2375584271","https://openalex.org/W1997105855","https://openalex.org/W2092424613","https://openalex.org/W2792951836","https://openalex.org/W2442328659"],"abstract_inverted_index":{"Association":[0],"between":[1,47],"cfDNA":[2],"concentration":[3,10],"and":[4,24,50,54,74,81],"residual":[5,83],"cancer":[6,28,84],"burden":[7],"(RCB).":[8],"CfDNA":[9],"was":[11,31,63],"measured":[12],"in":[13],"the":[14,94],"plasma":[15],"of":[16],"patients":[17],"with":[18,99],"A.":[19],"hormone":[20],"receptor-positive":[21],"HER2-negative":[22],"(HR+HER2-)":[23],"B.":[25],"triple-negative":[26],"breast":[27],"(TNBC).":[29],"Blood":[30],"collected":[32],"at":[33],"pretreatment":[34],"(T0),":[35],"3":[36],"weeks":[37,43],"after":[38,44,55,85],"treatment":[39,45,49],"initiation":[40,46],"(T1),":[41],"12":[42],"paclitaxel-based":[48],"anthracycline":[51],"regimens":[52],"(T2),":[53],"neoadjuvant":[56],"chemotherapy":[57],"(NAC)":[58],"before":[59],"surgery":[60],"(T3).":[61],"RCB":[62],"divided":[64],"into":[65],"4":[66],"classes:":[67],"RCB-0,":[68],"equivalent":[69],"to":[70,102],"pathologic":[71],"complete":[72],"response,":[73],"RCB-I,":[75],"-II,":[76],"-III,":[77],"representing":[78],"limited,":[79],"moderate,":[80],"extensive":[82],"NAC,":[86],"respectively.":[87],"Pairwise":[88],"P":[89],"values":[90],"were":[91],"calculated":[92],"using":[93],"Wilcoxon":[95],"rank":[96],"sum":[97],"test,":[98],"Bonferroni":[100],"correction":[101],"adjust":[103],"for":[104],"multiple":[105],"comparisons.":[106]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}